Phase I trial and pharmacokinetic study of all-trans-retinoic acid administered on an intermittent schedule in combination with interferon-alpha2a in pediatric patients with refractory cancer.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples